Literature DB >> 11344298

Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands.

G Tocchini-Valentini1, N Rochel, J M Wurtz, A Mitschler, D Moras.   

Abstract

The crystal structures of the ligand-binding domain (LBD) of the vitamin D receptor complexed to 1alpha,25(OH)(2)D(3) and the 20-epi analogs, MC1288 and KH1060, show that the protein conformation is identical, conferring a general character to the observation first made for retinoic acid receptor (RAR) that, for a given LBD, the agonist conformation is unique, the ligands adapting to the binding pocket. In all complexes, the A- to D-ring moieties of the ligands adopt the same conformation and form identical contacts with the protein. Differences are observed only for the 17beta-aliphatic chains that adapt their conformation to anchor the 25-hydroxyl group to His-305 and His-397. The inverted geometry of the C20 methyl group induces different paths of the aliphatic chains. The ligands exhibit a low-energy conformation for MC1288 and a more strained conformation for the two others. KH1060 compensates this energy cost by additional contacts. Based on the present data, the explanation of the superagonist effect is to be found in higher stability and longer half-life of the active complex, thereby excluding different conformations of the ligand binding domain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344298      PMCID: PMC33240          DOI: 10.1073/pnas.091018698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Annealing in crystallography: a powerful optimization tool.

Authors:  A T Brunger; P D Adams; L M Rice
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

Review 2.  Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.

Authors:  N J McKenna; J Xu; Z Nawaz; S Y Tsai; M J Tsai; B W O'Malley
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

3.  Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARgamma.

Authors:  B P Klaholz; A Mitschler; M Belema; C Zusi; D Moras
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.

Authors:  N Rochel; J M Wurtz; A Mitschler; B Klaholz; D Moras
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

5.  The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes.

Authors:  C Rachez; M Gamble; C P Chang; G B Atkins; M A Lazar; L P Freedman
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  Structure-function studies of new C-20 epimer pairs of vitamin D3 analogs.

Authors:  S Väisänen; S Ryhänen; J T Saarela; P H Mäenpää
Journal:  Eur J Biochem       Date:  1999-05

7.  20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor.

Authors:  W Yang; L P Freedman
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

8.  Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex.

Authors:  C Rachez; B D Lemon; Z Suldan; V Bromleigh; M Gamble; A M Näär; H Erdjument-Bromage; P Tempst; L P Freedman
Journal:  Nature       Date:  1999-04-29       Impact factor: 49.962

9.  Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties.

Authors:  A C Lavigne; G Mengus; Y G Gangloff; J M Wurtz; I Davidson
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

10.  Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.

Authors:  K Yamamoto; H Masuno; M Choi; K Nakashima; T Taga; H Ooizumi; K Umesono; W Sicinska; J VanHooke; H F DeLuca; S Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

View more
  43 in total

1.  Design, synthesis, and biological action of 20R-hydroxyvitamin D3.

Authors:  Yan Lu; Jianjun Chen; Zorica Janjetovic; Phillip Michaels; Edith K Y Tang; Jin Wang; Robert C Tuckey; Andrzej T Slominski; Wei Li; Duane D Miller
Journal:  J Med Chem       Date:  2012-03-20       Impact factor: 7.446

Review 2.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

3.  Thr176 regulates the activity of the mouse nuclear receptor CAR and is conserved in the NR1I subfamily members PXR and VDR.

Authors:  Akiko Ueda; Kenji Matsui; Yukio Yamamoto; Lars C Pedersen; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

Review 4.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

5.  New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model.

Authors:  Mathew T Mizwicki; Craig M Bula; June E Bishop; Anthony W Norman
Journal:  J Steroid Biochem Mol Biol       Date:  2007-03       Impact factor: 4.292

6.  Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings.

Authors:  Natacha Rochel; Fabrice Ciesielski; Julien Godet; Edelmiro Moman; Manfred Roessle; Carole Peluso-Iltis; Martine Moulin; Michael Haertlein; Phil Callow; Yves Mély; Dmitri I Svergun; Dino Moras
Journal:  Nat Struct Mol Biol       Date:  2011-04-10       Impact factor: 15.369

7.  Ligand-specific structural changes in the vitamin D receptor in solution.

Authors:  Kiran K Singarapu; Jinge Zhu; Marco Tonelli; Hongyu Rao; Fariba M Assadi-Porter; William M Westler; Hector F DeLuca; John L Markley
Journal:  Biochemistry       Date:  2011-12-05       Impact factor: 3.162

8.  A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications.

Authors:  Mathew T Mizwicki; Danusa Menegaz; Sepideh Yaghmaei; Helen L Henry; Anthony W Norman
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-14       Impact factor: 4.292

Review 9.  Vitamin D metabolism, mechanism of action, and clinical applications.

Authors:  Daniel D Bikle
Journal:  Chem Biol       Date:  2014-02-13

10.  Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.

Authors:  Mathew T Mizwicki; Don Keidel; Craig M Bula; June E Bishop; Laura P Zanello; Jean-Marie Wurtz; Dino Moras; Anthony W Norman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.